The purpose of this study is to look at whether Advair® and SYMBICORT® have different effects on airway constriction by means of methacholine challenge testing.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
20
45/4.5 two puffs twice daily
80/4.5 two puffs twice daily
National Jewish Health
Denver, Colorado, United States
Improvement in PC20
Improvements in PC20 as measured by methacholine challenge between the two treatment groups at the end of the first 4 week period to determine efficacy between low dose Advair and Symbicort.
Time frame: A baseline methacholine challenge was compared to the methacholine challenge performed after 4 weeks of treatment for each arm.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.